{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:26:45Z","timestamp":1791638805919,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.seizure.2024.04.009","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T11:32:10Z","timestamp":1712748730000},"page":"71-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effectiveness and safety of Lacosamide in pediatric patients with epilepsy under four years: Results from a prospective cohort study in China"],"prefix":"10.1016","volume":"118","author":[{"given":"Li","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tailin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 7","key":"10.1016\/j.seizure.2024.04.009_bib0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1528-1167.2011.03121.x","article-title":"Standards for epidemiologic studies and surveillance of epilepsy","volume":"52","author":"Thurman","year":"2011","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.seizure.2024.04.009_bib0002","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1046\/j.1528-1157.2002.t01-1-26901.x","article-title":"Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures","volume":"43","author":"Kotsopoulos","year":"2002","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2024.04.009_bib0003","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1167.2008.01981.x","article-title":"Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures","volume":"50","author":"Pi\u00f1a-Garza","year":"2009","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2024.04.009_bib0004","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1528-1167.2007.01188.x","article-title":"Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2024.04.009_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1528-1167.2008.01951.x","article-title":"Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial","volume":"50","author":"Hal\u00e1sz","year":"2009","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2024.04.009_bib0006","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1528-1167.2009.02496.x","article-title":"Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial","volume":"51","author":"Chung","year":"2010","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.seizure.2024.04.009_bib0007","doi-asserted-by":"crossref","first-page":"e1212","DOI":"10.1212\/WNL.0000000000008126","article-title":"Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures","volume":"93","author":"Farkas","year":"2019","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.seizure.2024.04.009_bib0008","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/jnnp-2020-323524","article-title":"Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial","volume":"91","author":"Vossler","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.seizure.2024.04.009_bib0009","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/epi.13466","article-title":"Lacosamide use in children with epilepsy: retention rate and effect of concomitant sodium channel blockers in a large cohort","volume":"57","author":"McGinnis","year":"2016","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2024.04.009_bib0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejpn.2019.05.002","article-title":"Role of observational studies in supporting extrapolation of efficacy data from adults to children with epilepsy - A systematic review of the literature using lacosamide as an example","volume":"23","author":"Arzimanoglou","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2024.04.009_bib0011","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40263-018-0523-7","article-title":"Lacosamide: a review in focal-onset seizures in patients with epilepsy","volume":"32","author":"Hoy","year":"2018","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.seizure.2024.04.009_bib0012","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/epi.14071","article-title":"Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: a single-center observational study","volume":"59","author":"Rosati","year":"2018","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2024.04.009_bib0013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11636260-000000000-00000","article-title":"Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain","volume":"12","author":"Casas-Fern\u00e1ndez","year":"2012","journal-title":"Drugs R D"},{"issue":"1","key":"10.1016\/j.seizure.2024.04.009_bib0014","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejpn.2013.08.006","article-title":"Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy","volume":"18","author":"Grosso","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2024.04.009_bib0015","article-title":"Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur","volume":"117","author":"Zhao","year":"2021","journal-title":"China. Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.seizure.2024.04.009_bib0016","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.seizure.2012.12.009","article-title":"Lacosamide in pediatric and adult patients: comparison of efficacy and safety","volume":"22","author":"Verrotti","year":"2013","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.seizure.2024.04.009_bib0017","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2024.04.009_bib0018","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00913694","article-title":"The Gesell Developmental Schedules: Arnold Gesell (1880-1961)","volume":"5","author":"Ball","year":"1977","journal-title":"J Abnorm Child Psychol"},{"issue":"4","key":"10.1016\/j.seizure.2024.04.009_bib0019","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.yebeh.2011.02.005","article-title":"Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy","volume":"20","author":"Gavatha","year":"2011","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2024.04.009_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejpn.2011.08.007","article-title":"Preliminary efficacy and safety of lacosamide in children with refractory epilepsy","volume":"16","author":"Heyman","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"issue":"8","key":"10.1016\/j.seizure.2024.04.009_bib0021","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/jpc.12850","article-title":"Lacosamide as adjunctive therapy in treatment-resistant epilepsy in childhood","volume":"51","author":"Gulati","year":"2015","journal-title":"J Paediatr Child Health"},{"issue":"7","key":"10.1016\/j.seizure.2024.04.009_bib0022","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/0883073816630084","article-title":"Efficacy and tolerability of lacosamide in the treatment of children with refractory generalized epilepsy","volume":"31","author":"Miskin","year":"2016","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2024.04.009_bib0023","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jpc.14156","article-title":"Lacosamide in children with drug-resistant epilepsy","volume":"55","author":"R\u00fcegger","year":"2019","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.seizure.2024.04.009_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108397","article-title":"Effectiveness of lacosamide in children and young adults previously treated with other sodium channel blockers","volume":"125","author":"Suzuki","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2024.04.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/epi.17676","article-title":"Safety of intravenous lacosamide in hospitalized children and neonates","author":"Fong","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2024.04.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108614","article-title":"Clinical impact of the dose and blood concentration of lacosamide in Japanese pediatric patients with epilepsy: a cohort study","volume":"129","author":"Ishikawa","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"7","key":"10.1016\/j.seizure.2024.04.009_bib0027","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/epi.12681","article-title":"Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study","volume":"55","author":"Wechsler","year":"2014","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.seizure.2024.04.009_bib0028","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/epi.13502","article-title":"Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: results from a multicenter, open-label trial","volume":"57","author":"Vossler","year":"2016","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2024.04.009_bib0029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(16)30292-7","article-title":"Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial","volume":"16","author":"Baulac","year":"2017","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2024.04.009_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0883073812462887","article-title":"Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy","volume":"29","author":"Yorns","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2024.04.009_bib0031","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.seizure.2020.04.016","article-title":"Efficacy and tolerability of treatment with lacosamide in children: postmarketing experience from the Middle East","volume":"79","author":"Hmaimess","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2024.04.009_bib0032","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2023.01.018","article-title":"Twelve-month efficacy of lacosamide monotherapy at maximal dose and tolerability for epilepsy treatment in pediatric patients: real-world clinical experience","volume":"142","author":"Zhao","year":"2023","journal-title":"Pediatr Neurol"},{"issue":"10","key":"10.1016\/j.seizure.2024.04.009_bib0033","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/epi.13869","article-title":"Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: a long-term study of 136 patients","volume":"58","author":"B\u00f6ttcher","year":"2017","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2024.04.009_bib0034","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.seizure.2006.12.001","article-title":"Retention rate of levetiracetam in children with intractable epilepsy at 1 year","volume":"16","author":"Peake","year":"2007","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.seizure.2024.04.009_bib0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.seizure.2011.01.011","article-title":"Retention rate of clobazam, topiramate and lamotrigine in children with intractable epilepsies at 1 year","volume":"20","author":"Mills","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2024.04.009_bib0036","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yebeh.2017.11.024","article-title":"The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting","volume":"79","author":"Sanmart\u00ed-Vilaplana","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.seizure.2024.04.009_bib0037","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pediatrneurol.2014.07.004","article-title":"Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy","volume":"51","author":"Pasha","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2024.04.009_bib0038","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pediatrneurol.2010.12.003","article-title":"Experience with lacosamide in a series of children with drug-resistant focal epilepsy","volume":"44","author":"Guilhoto","year":"2011","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2024.04.009_bib0039","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/0883073812436741","article-title":"Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study","volume":"27","author":"Rastogi","year":"2012","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2024.04.009_bib0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1468-1331.2006.01215.x","article-title":"Diagnosing refractory epilepsy: response to sequential treatment schedules","volume":"13","author":"Mohanraj","year":"2006","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2024.04.009_bib0041","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2024.04.009_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108781","article-title":"Efficacy and safety of lacosamide in pediatric patients with epilepsy: a systematic review and meta-analysis","volume":"134","author":"Yang","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.seizure.2024.04.009_bib0043","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/epi.17237","article-title":"Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2024.04.009_bib0044","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ane.12221","article-title":"Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome","volume":"129","author":"Grosso","year":"2014","journal-title":"Acta Neurol Scand"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124001006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124001006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:11:51Z","timestamp":1762362711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131124001006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":44,"alternative-id":["S1059131124001006"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2024.04.009","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of Lacosamide in pediatric patients with epilepsy under four years: Results from a prospective cohort study in China","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2024.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}